Enduring value guardian$Novo Nordisk AS(NVO.US)13:31:57 May 6, Cailian Press - Novo Nordisk's adjusted operating profit for the first quarter of 2026 reached 32.858 billion Danish kroner. Driven by upward revisions to GLP-1 product sales expectations, the company raised its performance outlook for 2026. It is expected that full-year adjusted sales will decline by 4% to 12% year-on-year, compared to the previous forecast of a 5% to 13% decline.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
